nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofarabine—RRM2—Hydroxyurea—psoriasis	0.364	0.453	CbGbCtD
Clofarabine—RRM1—Hydroxyurea—psoriasis	0.364	0.453	CbGbCtD
Clofarabine—ABCG2—Mycophenolate mofetil—psoriasis	0.0217	0.027	CbGbCtD
Clofarabine—ABCG2—Hydrocortisone—psoriasis	0.0174	0.0217	CbGbCtD
Clofarabine—ABCG2—Cyclosporine—psoriasis	0.0164	0.0205	CbGbCtD
Clofarabine—ABCG2—Dexamethasone—psoriasis	0.0108	0.0135	CbGbCtD
Clofarabine—ABCG2—Methotrexate—psoriasis	0.0087	0.0108	CbGbCtD
Clofarabine—RRM2—G1/S-Specific Transcription—PCNA—psoriasis	0.000903	0.0565	CbGpPWpGaD
Clofarabine—POLA1—Leading Strand Synthesis—PCNA—psoriasis	0.000722	0.0451	CbGpPWpGaD
Clofarabine—POLA1—Removal of the Flap Intermediate—PCNA—psoriasis	0.000722	0.0451	CbGpPWpGaD
Clofarabine—POLA1—Processive synthesis on the lagging strand—PCNA—psoriasis	0.000649	0.0405	CbGpPWpGaD
Clofarabine—POLA1—G1/S-Specific Transcription—PCNA—psoriasis	0.000618	0.0386	CbGpPWpGaD
Clofarabine—DCK—Purine metabolism—CAT—psoriasis	0.000576	0.036	CbGpPWpGaD
Clofarabine—RRM2—E2F mediated regulation of DNA replication—PCNA—psoriasis	0.000531	0.0332	CbGpPWpGaD
Clofarabine—POLA1—Lagging Strand Synthesis—PCNA—psoriasis	0.000522	0.0326	CbGpPWpGaD
Clofarabine—POLA1—Telomere C-strand (Lagging Strand) Synthesis—PCNA—psoriasis	0.000485	0.0303	CbGpPWpGaD
Clofarabine—POLA1—Extension of Telomeres—PCNA—psoriasis	0.000403	0.0252	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.000389	0.0243	CbGpPWpGaD
Clofarabine—RRM1—Nucleotide metabolism—CAT—psoriasis	0.000376	0.0235	CbGpPWpGaD
Clofarabine—POLA1—DNA strand elongation—PCNA—psoriasis	0.000373	0.0233	CbGpPWpGaD
Clofarabine—POLA1—E2F mediated regulation of DNA replication—PCNA—psoriasis	0.000363	0.0227	CbGpPWpGaD
Clofarabine—ABCG2—Iron uptake and transport—CP—psoriasis	0.000318	0.0199	CbGpPWpGaD
Clofarabine—DCK—Desoximetasone—Clobetasol propionate—psoriasis	0.000318	0.0833	CbGdCrCtD
Clofarabine—RRM2—Nucleotide metabolism—CAT—psoriasis	0.00031	0.0194	CbGpPWpGaD
Clofarabine—DCK—Diflorasone—Clobetasol propionate—psoriasis	0.000308	0.0809	CbGdCrCtD
Clofarabine—POLA1—DNA Replication—PCNA—psoriasis	0.0003	0.0187	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—PCNA—psoriasis	0.000297	0.0186	CbGpPWpGaD
Clofarabine—DCK—Nucleotide metabolism—CAT—psoriasis	0.00029	0.0181	CbGpPWpGaD
Clofarabine—DCK—Desoximetasone—Fluocinonide—psoriasis	0.000255	0.0667	CbGdCrCtD
Clofarabine—DCK—Desoximetasone—Beclomethasone—psoriasis	0.000255	0.0667	CbGdCrCtD
Clofarabine—DCK—Desoximetasone—Fluocinolone Acetonide—psoriasis	0.000247	0.0648	CbGdCrCtD
Clofarabine—DCK—Diflorasone—Beclomethasone—psoriasis	0.000247	0.0648	CbGdCrCtD
Clofarabine—DCK—Diflorasone—Fluocinonide—psoriasis	0.000247	0.0648	CbGdCrCtD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—PCNA—psoriasis	0.000245	0.0153	CbGpPWpGaD
Clofarabine—DCK—Diflorasone—Fluocinolone Acetonide—psoriasis	0.00024	0.0629	CbGdCrCtD
Clofarabine—RRM1—Fluoropyrimidine Activity—TP53—psoriasis	0.000237	0.0148	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—PCNA—psoriasis	0.000229	0.0143	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—CP—psoriasis	0.000226	0.0141	CbGpPWpGaD
Clofarabine—POLA1—Norethindrone—Hydrocortisone—psoriasis	0.000223	0.0584	CbGdCrCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.000219	0.0137	CbGpPWpGaD
Clofarabine—RRM2—G1/S Transition—PCNA—psoriasis	0.000204	0.0128	CbGpPWpGaD
Clofarabine—RRM2—Fluoropyrimidine Activity—TP53—psoriasis	0.000195	0.0122	CbGpPWpGaD
Clofarabine—POLA1—Telomere Maintenance—PCNA—psoriasis	0.000183	0.0114	CbGpPWpGaD
Clofarabine—POLA1—Levonorgestrel—Hydrocortisone—psoriasis	0.000177	0.0464	CbGdCrCtD
Clofarabine—RRM2—Mitotic G1-G1/S phases—PCNA—psoriasis	0.000172	0.0108	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—PCNA—psoriasis	0.000167	0.0105	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	0.000158	0.0099	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—PTTG1—psoriasis	0.000155	0.00968	CbGpPWpGaD
Clofarabine—POLA1—Synthesis of DNA—PCNA—psoriasis	0.000155	0.00967	CbGpPWpGaD
Clofarabine—POLA1—Chromosome Maintenance—PCNA—psoriasis	0.000152	0.00951	CbGpPWpGaD
Clofarabine—POLA1—DNA Replication—PCNA—psoriasis	0.000145	0.00907	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—PTTG1—psoriasis	0.000142	0.00885	CbGpPWpGaD
Clofarabine—POLA1—G1/S Transition—PCNA—psoriasis	0.00014	0.00873	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—PTTG1—psoriasis	0.000139	0.00866	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—NDUFA5—psoriasis	0.000134	0.00836	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	0.000133	0.00832	CbGpPWpGaD
Clofarabine—POLA1—S Phase—PCNA—psoriasis	0.000127	0.00793	CbGpPWpGaD
Clofarabine—DCK—Desoximetasone—Hydrocortisone—psoriasis	0.000125	0.0328	CbGdCrCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—PCNA—psoriasis	0.000118	0.00736	CbGpPWpGaD
Clofarabine—DCK—Desoximetasone—Dexamethasone—psoriasis	0.000116	0.0304	CbGdCrCtD
Clofarabine—DCK—Desoximetasone—Betamethasone—psoriasis	0.000116	0.0304	CbGdCrCtD
Clofarabine—RRM1—Metabolism—CYP2S1—psoriasis	0.000114	0.00711	CbGpPWpGaD
Clofarabine—DCK—Desoximetasone—Triamcinolone—psoriasis	0.000113	0.0297	CbGdCrCtD
Clofarabine—DCK—Diflorasone—Dexamethasone—psoriasis	0.000113	0.0295	CbGdCrCtD
Clofarabine—DCK—Diflorasone—Betamethasone—psoriasis	0.000113	0.0295	CbGdCrCtD
Clofarabine—RRM2—Metabolism—NDUFA5—psoriasis	0.00011	0.00689	CbGpPWpGaD
Clofarabine—DCK—Diflorasone—Triamcinolone—psoriasis	0.00011	0.0288	CbGdCrCtD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—psoriasis	0.000109	0.00683	CbGpPWpGaD
Clofarabine—DCK—Desoximetasone—Prednisone—psoriasis	0.000108	0.0282	CbGdCrCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—PTTG1—psoriasis	0.000106	0.00662	CbGpPWpGaD
Clofarabine—DCK—Desoximetasone—Prednisolone—psoriasis	0.000105	0.0275	CbGdCrCtD
Clofarabine—DCK—Diflorasone—Prednisone—psoriasis	0.000104	0.0274	CbGdCrCtD
Clofarabine—DCK—Metabolism—NDUFA5—psoriasis	0.000103	0.00644	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—LEP—psoriasis	0.000103	0.00643	CbGpPWpGaD
Clofarabine—DCK—Diflorasone—Prednisolone—psoriasis	0.000102	0.0267	CbGdCrCtD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—NOS2—psoriasis	9.59e-05	0.00599	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—PTTG1—psoriasis	9.47e-05	0.00592	CbGpPWpGaD
Clofarabine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—psoriasis	9.44e-05	0.0059	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CYP2S1—psoriasis	9.37e-05	0.00586	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—TP53—psoriasis	9e-05	0.00562	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	8.92e-05	0.00558	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	8.82e-05	0.00551	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CYP2S1—psoriasis	8.76e-05	0.00547	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	8.49e-05	0.00531	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—psoriasis	8.41e-05	0.00525	CbGpPWpGaD
Clofarabine—Infestation NOS—Methotrexate—psoriasis	7.74e-05	0.000439	CcSEcCtD
Clofarabine—Flushing—Prednisone—psoriasis	7.71e-05	0.000437	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Cyclosporine—psoriasis	7.71e-05	0.000437	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	7.71e-05	0.00482	CbGpPWpGaD
Clofarabine—Skin disorder—Hydrocortisone—psoriasis	7.71e-05	0.000437	CcSEcCtD
Clofarabine—Fatigue—Cyclosporine—psoriasis	7.7e-05	0.000436	CcSEcCtD
Clofarabine—Hyperhidrosis—Hydrocortisone—psoriasis	7.67e-05	0.000435	CcSEcCtD
Clofarabine—Stevens-Johnson syndrome—Methotrexate—psoriasis	7.67e-05	0.000435	CcSEcCtD
Clofarabine—Pain—Cyclosporine—psoriasis	7.64e-05	0.000433	CcSEcCtD
Clofarabine—Renal failure—Methotrexate—psoriasis	7.6e-05	0.000431	CcSEcCtD
Clofarabine—Decreased appetite—Mycophenolate mofetil—psoriasis	7.57e-05	0.000429	CcSEcCtD
Clofarabine—Anorexia—Hydrocortisone—psoriasis	7.56e-05	0.000429	CcSEcCtD
Clofarabine—Diarrhoea—Mycophenolic acid—psoriasis	7.55e-05	0.000428	CcSEcCtD
Clofarabine—Stomatitis—Methotrexate—psoriasis	7.54e-05	0.000428	CcSEcCtD
Clofarabine—Angiopathy—Prednisone—psoriasis	7.54e-05	0.000427	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	7.52e-05	0.000426	CcSEcCtD
Clofarabine—Immune system disorder—Prednisone—psoriasis	7.51e-05	0.000426	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	7.5e-05	0.00468	CbGpPWpGaD
Clofarabine—Oedema—Triamcinolone—psoriasis	7.47e-05	0.000424	CcSEcCtD
Clofarabine—Pain—Mycophenolate mofetil—psoriasis	7.45e-05	0.000422	CcSEcCtD
Clofarabine—Infection—Triamcinolone—psoriasis	7.42e-05	0.000421	CcSEcCtD
Clofarabine—Hypotension—Hydrocortisone—psoriasis	7.41e-05	0.00042	CcSEcCtD
Clofarabine—Haematuria—Methotrexate—psoriasis	7.38e-05	0.000418	CcSEcCtD
Clofarabine—Feeling abnormal—Cyclosporine—psoriasis	7.36e-05	0.000417	CcSEcCtD
Clofarabine—Alopecia—Prednisone—psoriasis	7.34e-05	0.000416	CcSEcCtD
Clofarabine—Hepatobiliary disease—Methotrexate—psoriasis	7.32e-05	0.000415	CcSEcCtD
Clofarabine—ABCG2—Fluoropyrimidine Activity—TP53—psoriasis	7.31e-05	0.00457	CbGpPWpGaD
Clofarabine—DCK—Levonorgestrel—Hydrocortisone—psoriasis	7.3e-05	0.0191	CbGdCrCtD
Clofarabine—Gastrointestinal pain—Cyclosporine—psoriasis	7.3e-05	0.000414	CcSEcCtD
Clofarabine—Dizziness—Mycophenolic acid—psoriasis	7.3e-05	0.000414	CcSEcCtD
Clofarabine—Epistaxis—Methotrexate—psoriasis	7.3e-05	0.000414	CcSEcCtD
Clofarabine—Paraesthesia—Prednisolone—psoriasis	7.3e-05	0.000414	CcSEcCtD
Clofarabine—Tachycardia—Triamcinolone—psoriasis	7.29e-05	0.000413	CcSEcCtD
Clofarabine—Mental disorder—Prednisone—psoriasis	7.28e-05	0.000413	CcSEcCtD
Clofarabine—Malnutrition—Prednisone—psoriasis	7.23e-05	0.00041	CcSEcCtD
Clofarabine—Erythema—Prednisone—psoriasis	7.23e-05	0.00041	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Hydrocortisone—psoriasis	7.23e-05	0.00041	CcSEcCtD
Clofarabine—Hyperhidrosis—Triamcinolone—psoriasis	7.22e-05	0.00041	CcSEcCtD
Clofarabine—Feeling abnormal—Mycophenolate mofetil—psoriasis	7.18e-05	0.000407	CcSEcCtD
Clofarabine—Hypertension—Betamethasone—psoriasis	7.17e-05	0.000407	CcSEcCtD
Clofarabine—Hypertension—Dexamethasone—psoriasis	7.17e-05	0.000407	CcSEcCtD
Clofarabine—Paraesthesia—Hydrocortisone—psoriasis	7.13e-05	0.000404	CcSEcCtD
Clofarabine—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	7.12e-05	0.000404	CcSEcCtD
Clofarabine—Myalgia—Dexamethasone—psoriasis	7.07e-05	0.000401	CcSEcCtD
Clofarabine—Myalgia—Betamethasone—psoriasis	7.07e-05	0.000401	CcSEcCtD
Clofarabine—Body temperature increased—Cyclosporine—psoriasis	7.06e-05	0.0004	CcSEcCtD
Clofarabine—Abdominal pain—Cyclosporine—psoriasis	7.06e-05	0.0004	CcSEcCtD
Clofarabine—Anxiety—Betamethasone—psoriasis	7.05e-05	0.0004	CcSEcCtD
Clofarabine—Anxiety—Dexamethasone—psoriasis	7.05e-05	0.0004	CcSEcCtD
Clofarabine—Vomiting—Mycophenolic acid—psoriasis	7.02e-05	0.000398	CcSEcCtD
Clofarabine—Haemoglobin—Methotrexate—psoriasis	6.98e-05	0.000396	CcSEcCtD
Clofarabine—Rash—Mycophenolic acid—psoriasis	6.96e-05	0.000395	CcSEcCtD
Clofarabine—Dermatitis—Mycophenolic acid—psoriasis	6.95e-05	0.000394	CcSEcCtD
Clofarabine—Pain—Prednisolone—psoriasis	6.95e-05	0.000394	CcSEcCtD
Clofarabine—Haemorrhage—Methotrexate—psoriasis	6.94e-05	0.000394	CcSEcCtD
Clofarabine—Headache—Mycophenolic acid—psoriasis	6.91e-05	0.000392	CcSEcCtD
Clofarabine—Decreased appetite—Hydrocortisone—psoriasis	6.9e-05	0.000391	CcSEcCtD
Clofarabine—Body temperature increased—Mycophenolate mofetil—psoriasis	6.89e-05	0.00039	CcSEcCtD
Clofarabine—Abdominal pain—Mycophenolate mofetil—psoriasis	6.89e-05	0.00039	CcSEcCtD
Clofarabine—Urinary tract disorder—Methotrexate—psoriasis	6.86e-05	0.000389	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Hydrocortisone—psoriasis	6.85e-05	0.000388	CcSEcCtD
Clofarabine—Fatigue—Hydrocortisone—psoriasis	6.84e-05	0.000388	CcSEcCtD
Clofarabine—Urethral disorder—Methotrexate—psoriasis	6.81e-05	0.000386	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Triamcinolone—psoriasis	6.81e-05	0.000386	CcSEcCtD
Clofarabine—Pain—Hydrocortisone—psoriasis	6.79e-05	0.000385	CcSEcCtD
Clofarabine—Oedema—Dexamethasone—psoriasis	6.78e-05	0.000384	CcSEcCtD
Clofarabine—Oedema—Betamethasone—psoriasis	6.78e-05	0.000384	CcSEcCtD
Clofarabine—Infection—Dexamethasone—psoriasis	6.74e-05	0.000382	CcSEcCtD
Clofarabine—Infection—Betamethasone—psoriasis	6.74e-05	0.000382	CcSEcCtD
Clofarabine—Paraesthesia—Triamcinolone—psoriasis	6.71e-05	0.00038	CcSEcCtD
Clofarabine—Feeling abnormal—Prednisolone—psoriasis	6.7e-05	0.00038	CcSEcCtD
Clofarabine—Anaemia—Prednisone—psoriasis	6.69e-05	0.000379	CcSEcCtD
Clofarabine—Dyspnoea—Triamcinolone—psoriasis	6.66e-05	0.000378	CcSEcCtD
Clofarabine—Nervous system disorder—Dexamethasone—psoriasis	6.65e-05	0.000377	CcSEcCtD
Clofarabine—Nervous system disorder—Betamethasone—psoriasis	6.65e-05	0.000377	CcSEcCtD
Clofarabine—Agitation—Prednisone—psoriasis	6.65e-05	0.000377	CcSEcCtD
Clofarabine—Thrombocytopenia—Dexamethasone—psoriasis	6.64e-05	0.000376	CcSEcCtD
Clofarabine—Thrombocytopenia—Betamethasone—psoriasis	6.64e-05	0.000376	CcSEcCtD
Clofarabine—Tachycardia—Dexamethasone—psoriasis	6.62e-05	0.000375	CcSEcCtD
Clofarabine—Tachycardia—Betamethasone—psoriasis	6.62e-05	0.000375	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	6.61e-05	0.00413	CbGpPWpGaD
Clofarabine—Hypersensitivity—Cyclosporine—psoriasis	6.58e-05	0.000373	CcSEcCtD
Clofarabine—Erythema multiforme—Methotrexate—psoriasis	6.57e-05	0.000372	CcSEcCtD
Clofarabine—Nausea—Mycophenolic acid—psoriasis	6.56e-05	0.000372	CcSEcCtD
Clofarabine—Hyperhidrosis—Dexamethasone—psoriasis	6.55e-05	0.000372	CcSEcCtD
Clofarabine—Hyperhidrosis—Betamethasone—psoriasis	6.55e-05	0.000372	CcSEcCtD
Clofarabine—Feeling abnormal—Hydrocortisone—psoriasis	6.54e-05	0.000371	CcSEcCtD
Clofarabine—Gastrointestinal pain—Hydrocortisone—psoriasis	6.49e-05	0.000368	CcSEcCtD
Clofarabine—Anorexia—Betamethasone—psoriasis	6.46e-05	0.000366	CcSEcCtD
Clofarabine—Anorexia—Dexamethasone—psoriasis	6.46e-05	0.000366	CcSEcCtD
Clofarabine—Cardiac disorder—Methotrexate—psoriasis	6.45e-05	0.000365	CcSEcCtD
Clofarabine—Fatigue—Triamcinolone—psoriasis	6.44e-05	0.000365	CcSEcCtD
Clofarabine—Hypersensitivity—Mycophenolate mofetil—psoriasis	6.42e-05	0.000364	CcSEcCtD
Clofarabine—Asthenia—Cyclosporine—psoriasis	6.41e-05	0.000363	CcSEcCtD
Clofarabine—Pain—Triamcinolone—psoriasis	6.39e-05	0.000362	CcSEcCtD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—JUN—psoriasis	6.36e-05	0.00397	CbGpPWpGaD
Clofarabine—Hypotension—Dexamethasone—psoriasis	6.33e-05	0.000359	CcSEcCtD
Clofarabine—Hypotension—Betamethasone—psoriasis	6.33e-05	0.000359	CcSEcCtD
Clofarabine—Pruritus—Cyclosporine—psoriasis	6.32e-05	0.000358	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—PCNA—psoriasis	6.31e-05	0.00395	CbGpPWpGaD
Clofarabine—Angiopathy—Methotrexate—psoriasis	6.3e-05	0.000357	CcSEcCtD
Clofarabine—Immune system disorder—Methotrexate—psoriasis	6.27e-05	0.000356	CcSEcCtD
Clofarabine—Body temperature increased—Hydrocortisone—psoriasis	6.27e-05	0.000356	CcSEcCtD
Clofarabine—Abdominal pain—Hydrocortisone—psoriasis	6.27e-05	0.000356	CcSEcCtD
Clofarabine—Mediastinal disorder—Methotrexate—psoriasis	6.26e-05	0.000355	CcSEcCtD
Clofarabine—Asthenia—Mycophenolate mofetil—psoriasis	6.25e-05	0.000354	CcSEcCtD
Clofarabine—Hypertension—Prednisone—psoriasis	6.25e-05	0.000354	CcSEcCtD
Clofarabine—Chills—Methotrexate—psoriasis	6.23e-05	0.000353	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Dexamethasone—psoriasis	6.18e-05	0.00035	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Betamethasone—psoriasis	6.18e-05	0.00035	CcSEcCtD
Clofarabine—Pruritus—Mycophenolate mofetil—psoriasis	6.16e-05	0.000349	CcSEcCtD
Clofarabine—Arthralgia—Prednisone—psoriasis	6.16e-05	0.000349	CcSEcCtD
Clofarabine—Myalgia—Prednisone—psoriasis	6.16e-05	0.000349	CcSEcCtD
Clofarabine—Feeling abnormal—Triamcinolone—psoriasis	6.16e-05	0.000349	CcSEcCtD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—psoriasis	6.15e-05	0.00385	CbGpPWpGaD
Clofarabine—Anxiety—Prednisone—psoriasis	6.14e-05	0.000348	CcSEcCtD
Clofarabine—Alopecia—Methotrexate—psoriasis	6.14e-05	0.000348	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	6.12e-05	0.000347	CcSEcCtD
Clofarabine—Diarrhoea—Cyclosporine—psoriasis	6.11e-05	0.000346	CcSEcCtD
Clofarabine—Paraesthesia—Dexamethasone—psoriasis	6.09e-05	0.000345	CcSEcCtD
Clofarabine—Paraesthesia—Betamethasone—psoriasis	6.09e-05	0.000345	CcSEcCtD
Clofarabine—Mental disorder—Methotrexate—psoriasis	6.08e-05	0.000345	CcSEcCtD
Clofarabine—Erythema—Methotrexate—psoriasis	6.05e-05	0.000343	CcSEcCtD
Clofarabine—Malnutrition—Methotrexate—psoriasis	6.05e-05	0.000343	CcSEcCtD
Clofarabine—Hypersensitivity—Prednisolone—psoriasis	5.99e-05	0.000339	CcSEcCtD
Clofarabine—Diarrhoea—Mycophenolate mofetil—psoriasis	5.96e-05	0.000338	CcSEcCtD
Clofarabine—Body temperature increased—Triamcinolone—psoriasis	5.91e-05	0.000335	CcSEcCtD
Clofarabine—Dizziness—Cyclosporine—psoriasis	5.9e-05	0.000335	CcSEcCtD
Clofarabine—Oedema—Prednisone—psoriasis	5.9e-05	0.000335	CcSEcCtD
Clofarabine—Decreased appetite—Dexamethasone—psoriasis	5.89e-05	0.000334	CcSEcCtD
Clofarabine—Decreased appetite—Betamethasone—psoriasis	5.89e-05	0.000334	CcSEcCtD
Clofarabine—Infection—Prednisone—psoriasis	5.87e-05	0.000333	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Dexamethasone—psoriasis	5.85e-05	0.000332	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Betamethasone—psoriasis	5.85e-05	0.000332	CcSEcCtD
Clofarabine—Back pain—Methotrexate—psoriasis	5.85e-05	0.000332	CcSEcCtD
Clofarabine—Hypersensitivity—Hydrocortisone—psoriasis	5.85e-05	0.000331	CcSEcCtD
Clofarabine—Fatigue—Betamethasone—psoriasis	5.84e-05	0.000331	CcSEcCtD
Clofarabine—Fatigue—Dexamethasone—psoriasis	5.84e-05	0.000331	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	5.82e-05	0.00364	CbGpPWpGaD
Clofarabine—Pain—Betamethasone—psoriasis	5.8e-05	0.000329	CcSEcCtD
Clofarabine—Pain—Dexamethasone—psoriasis	5.8e-05	0.000329	CcSEcCtD
Clofarabine—Nervous system disorder—Prednisone—psoriasis	5.79e-05	0.000328	CcSEcCtD
Clofarabine—Tachycardia—Prednisone—psoriasis	5.76e-05	0.000327	CcSEcCtD
Clofarabine—Dizziness—Mycophenolate mofetil—psoriasis	5.76e-05	0.000327	CcSEcCtD
Clofarabine—Skin disorder—Prednisone—psoriasis	5.73e-05	0.000325	CcSEcCtD
Clofarabine—Hyperhidrosis—Prednisone—psoriasis	5.71e-05	0.000324	CcSEcCtD
Clofarabine—Asthenia—Hydrocortisone—psoriasis	5.69e-05	0.000323	CcSEcCtD
Clofarabine—Vomiting—Cyclosporine—psoriasis	5.68e-05	0.000322	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—PCNA—psoriasis	5.65e-05	0.00353	CbGpPWpGaD
Clofarabine—Rash—Cyclosporine—psoriasis	5.63e-05	0.000319	CcSEcCtD
Clofarabine—Anorexia—Prednisone—psoriasis	5.63e-05	0.000319	CcSEcCtD
Clofarabine—Dermatitis—Cyclosporine—psoriasis	5.62e-05	0.000319	CcSEcCtD
Clofarabine—Pruritus—Hydrocortisone—psoriasis	5.61e-05	0.000318	CcSEcCtD
Clofarabine—Headache—Cyclosporine—psoriasis	5.59e-05	0.000317	CcSEcCtD
Clofarabine—Anaemia—Methotrexate—psoriasis	5.59e-05	0.000317	CcSEcCtD
Clofarabine—Feeling abnormal—Dexamethasone—psoriasis	5.59e-05	0.000317	CcSEcCtD
Clofarabine—Feeling abnormal—Betamethasone—psoriasis	5.59e-05	0.000317	CcSEcCtD
Clofarabine—RRM1—Metabolism—CARM1—psoriasis	5.56e-05	0.00347	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—psoriasis	5.55e-05	0.00347	CbGpPWpGaD
Clofarabine—Gastrointestinal pain—Dexamethasone—psoriasis	5.54e-05	0.000314	CcSEcCtD
Clofarabine—Gastrointestinal pain—Betamethasone—psoriasis	5.54e-05	0.000314	CcSEcCtD
Clofarabine—Vomiting—Mycophenolate mofetil—psoriasis	5.54e-05	0.000314	CcSEcCtD
Clofarabine—Hypersensitivity—Triamcinolone—psoriasis	5.5e-05	0.000312	CcSEcCtD
Clofarabine—Rash—Mycophenolate mofetil—psoriasis	5.49e-05	0.000311	CcSEcCtD
Clofarabine—Dermatitis—Mycophenolate mofetil—psoriasis	5.49e-05	0.000311	CcSEcCtD
Clofarabine—Headache—Mycophenolate mofetil—psoriasis	5.46e-05	0.000309	CcSEcCtD
Clofarabine—Diarrhoea—Hydrocortisone—psoriasis	5.43e-05	0.000308	CcSEcCtD
Clofarabine—Leukopenia—Methotrexate—psoriasis	5.41e-05	0.000307	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Prednisone—psoriasis	5.38e-05	0.000305	CcSEcCtD
Clofarabine—Dizziness—Prednisolone—psoriasis	5.37e-05	0.000305	CcSEcCtD
Clofarabine—Asthenia—Triamcinolone—psoriasis	5.36e-05	0.000304	CcSEcCtD
Clofarabine—Body temperature increased—Betamethasone—psoriasis	5.36e-05	0.000304	CcSEcCtD
Clofarabine—Abdominal pain—Betamethasone—psoriasis	5.36e-05	0.000304	CcSEcCtD
Clofarabine—Abdominal pain—Dexamethasone—psoriasis	5.36e-05	0.000304	CcSEcCtD
Clofarabine—Body temperature increased—Dexamethasone—psoriasis	5.36e-05	0.000304	CcSEcCtD
Clofarabine—Nausea—Cyclosporine—psoriasis	5.3e-05	0.000301	CcSEcCtD
Clofarabine—Paraesthesia—Prednisone—psoriasis	5.3e-05	0.000301	CcSEcCtD
Clofarabine—Pruritus—Triamcinolone—psoriasis	5.29e-05	0.0003	CcSEcCtD
Clofarabine—Cough—Methotrexate—psoriasis	5.28e-05	0.000299	CcSEcCtD
Clofarabine—Dizziness—Hydrocortisone—psoriasis	5.25e-05	0.000297	CcSEcCtD
Clofarabine—Nausea—Mycophenolate mofetil—psoriasis	5.17e-05	0.000293	CcSEcCtD
Clofarabine—Arthralgia—Methotrexate—psoriasis	5.15e-05	0.000292	CcSEcCtD
Clofarabine—Myalgia—Methotrexate—psoriasis	5.15e-05	0.000292	CcSEcCtD
Clofarabine—Decreased appetite—Prednisone—psoriasis	5.13e-05	0.000291	CcSEcCtD
Clofarabine—Rash—Prednisolone—psoriasis	5.12e-05	0.00029	CcSEcCtD
Clofarabine—Dermatitis—Prednisolone—psoriasis	5.12e-05	0.00029	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	5.11e-05	0.00029	CcSEcCtD
Clofarabine—Fatigue—Prednisone—psoriasis	5.09e-05	0.000289	CcSEcCtD
Clofarabine—Headache—Prednisolone—psoriasis	5.09e-05	0.000289	CcSEcCtD
Clofarabine—Vomiting—Hydrocortisone—psoriasis	5.05e-05	0.000286	CcSEcCtD
Clofarabine—Rash—Hydrocortisone—psoriasis	5e-05	0.000284	CcSEcCtD
Clofarabine—Dermatitis—Hydrocortisone—psoriasis	5e-05	0.000283	CcSEcCtD
Clofarabine—Headache—Hydrocortisone—psoriasis	4.97e-05	0.000282	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	4.97e-05	0.00311	CbGpPWpGaD
Clofarabine—Dizziness—Triamcinolone—psoriasis	4.94e-05	0.00028	CcSEcCtD
Clofarabine—Infection—Methotrexate—psoriasis	4.9e-05	0.000278	CcSEcCtD
Clofarabine—Feeling abnormal—Prednisone—psoriasis	4.87e-05	0.000276	CcSEcCtD
Clofarabine—Asthenia—Dexamethasone—psoriasis	4.86e-05	0.000276	CcSEcCtD
Clofarabine—Asthenia—Betamethasone—psoriasis	4.86e-05	0.000276	CcSEcCtD
Clofarabine—Nervous system disorder—Methotrexate—psoriasis	4.84e-05	0.000274	CcSEcCtD
Clofarabine—Thrombocytopenia—Methotrexate—psoriasis	4.83e-05	0.000274	CcSEcCtD
Clofarabine—Gastrointestinal pain—Prednisone—psoriasis	4.83e-05	0.000274	CcSEcCtD
Clofarabine—Nausea—Prednisolone—psoriasis	4.83e-05	0.000274	CcSEcCtD
Clofarabine—Pruritus—Betamethasone—psoriasis	4.8e-05	0.000272	CcSEcCtD
Clofarabine—Pruritus—Dexamethasone—psoriasis	4.8e-05	0.000272	CcSEcCtD
Clofarabine—Skin disorder—Methotrexate—psoriasis	4.79e-05	0.000272	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	4.78e-05	0.00299	CbGpPWpGaD
Clofarabine—Hyperhidrosis—Methotrexate—psoriasis	4.77e-05	0.00027	CcSEcCtD
Clofarabine—Vomiting—Triamcinolone—psoriasis	4.75e-05	0.000269	CcSEcCtD
Clofarabine—Nausea—Hydrocortisone—psoriasis	4.71e-05	0.000267	CcSEcCtD
Clofarabine—Rash—Triamcinolone—psoriasis	4.71e-05	0.000267	CcSEcCtD
Clofarabine—Dermatitis—Triamcinolone—psoriasis	4.71e-05	0.000267	CcSEcCtD
Clofarabine—Anorexia—Methotrexate—psoriasis	4.7e-05	0.000267	CcSEcCtD
Clofarabine—Headache—Triamcinolone—psoriasis	4.68e-05	0.000265	CcSEcCtD
Clofarabine—Body temperature increased—Prednisone—psoriasis	4.67e-05	0.000265	CcSEcCtD
Clofarabine—Abdominal pain—Prednisone—psoriasis	4.67e-05	0.000265	CcSEcCtD
Clofarabine—Diarrhoea—Betamethasone—psoriasis	4.64e-05	0.000263	CcSEcCtD
Clofarabine—Diarrhoea—Dexamethasone—psoriasis	4.64e-05	0.000263	CcSEcCtD
Clofarabine—Hypotension—Methotrexate—psoriasis	4.61e-05	0.000261	CcSEcCtD
Clofarabine—RRM2—Metabolism—CARM1—psoriasis	4.58e-05	0.00286	CbGpPWpGaD
Clofarabine—Musculoskeletal discomfort—Methotrexate—psoriasis	4.5e-05	0.000255	CcSEcCtD
Clofarabine—Dizziness—Dexamethasone—psoriasis	4.48e-05	0.000254	CcSEcCtD
Clofarabine—Dizziness—Betamethasone—psoriasis	4.48e-05	0.000254	CcSEcCtD
Clofarabine—Nausea—Triamcinolone—psoriasis	4.44e-05	0.000252	CcSEcCtD
Clofarabine—Paraesthesia—Methotrexate—psoriasis	4.43e-05	0.000251	CcSEcCtD
Clofarabine—Dyspnoea—Methotrexate—psoriasis	4.4e-05	0.000249	CcSEcCtD
Clofarabine—Somnolence—Methotrexate—psoriasis	4.39e-05	0.000249	CcSEcCtD
Clofarabine—Hypersensitivity—Prednisone—psoriasis	4.35e-05	0.000247	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	4.34e-05	0.00271	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—PCNA—psoriasis	4.32e-05	0.0027	CbGpPWpGaD
Clofarabine—Vomiting—Betamethasone—psoriasis	4.31e-05	0.000244	CcSEcCtD
Clofarabine—Vomiting—Dexamethasone—psoriasis	4.31e-05	0.000244	CcSEcCtD
Clofarabine—Decreased appetite—Methotrexate—psoriasis	4.29e-05	0.000243	CcSEcCtD
Clofarabine—DCK—Metabolism—CARM1—psoriasis	4.28e-05	0.00267	CbGpPWpGaD
Clofarabine—Rash—Dexamethasone—psoriasis	4.27e-05	0.000242	CcSEcCtD
Clofarabine—Rash—Betamethasone—psoriasis	4.27e-05	0.000242	CcSEcCtD
Clofarabine—Dermatitis—Dexamethasone—psoriasis	4.27e-05	0.000242	CcSEcCtD
Clofarabine—Dermatitis—Betamethasone—psoriasis	4.27e-05	0.000242	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Methotrexate—psoriasis	4.26e-05	0.000242	CcSEcCtD
Clofarabine—Fatigue—Methotrexate—psoriasis	4.25e-05	0.000241	CcSEcCtD
Clofarabine—Headache—Betamethasone—psoriasis	4.25e-05	0.000241	CcSEcCtD
Clofarabine—Headache—Dexamethasone—psoriasis	4.25e-05	0.000241	CcSEcCtD
Clofarabine—Asthenia—Prednisone—psoriasis	4.24e-05	0.00024	CcSEcCtD
Clofarabine—Pain—Methotrexate—psoriasis	4.22e-05	0.000239	CcSEcCtD
Clofarabine—Pruritus—Prednisone—psoriasis	4.18e-05	0.000237	CcSEcCtD
Clofarabine—ABCG2—Metabolism—NDUFA5—psoriasis	4.12e-05	0.00258	CbGpPWpGaD
Clofarabine—Feeling abnormal—Methotrexate—psoriasis	4.07e-05	0.000231	CcSEcCtD
Clofarabine—Diarrhoea—Prednisone—psoriasis	4.04e-05	0.000229	CcSEcCtD
Clofarabine—Gastrointestinal pain—Methotrexate—psoriasis	4.03e-05	0.000229	CcSEcCtD
Clofarabine—Nausea—Dexamethasone—psoriasis	4.03e-05	0.000228	CcSEcCtD
Clofarabine—Nausea—Betamethasone—psoriasis	4.03e-05	0.000228	CcSEcCtD
Clofarabine—Dizziness—Prednisone—psoriasis	3.9e-05	0.000221	CcSEcCtD
Clofarabine—Abdominal pain—Methotrexate—psoriasis	3.9e-05	0.000221	CcSEcCtD
Clofarabine—Body temperature increased—Methotrexate—psoriasis	3.9e-05	0.000221	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—PCNA—psoriasis	3.86e-05	0.00241	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—CP—psoriasis	3.83e-05	0.00239	CbGpPWpGaD
Clofarabine—Vomiting—Prednisone—psoriasis	3.75e-05	0.000213	CcSEcCtD
Clofarabine—Rash—Prednisone—psoriasis	3.72e-05	0.000211	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	3.72e-05	0.00233	CbGpPWpGaD
Clofarabine—Dermatitis—Prednisone—psoriasis	3.72e-05	0.000211	CcSEcCtD
Clofarabine—Headache—Prednisone—psoriasis	3.7e-05	0.00021	CcSEcCtD
Clofarabine—ABCG2—Transmembrane transport of small molecules—CARM1—psoriasis	3.65e-05	0.00228	CbGpPWpGaD
Clofarabine—Hypersensitivity—Methotrexate—psoriasis	3.64e-05	0.000206	CcSEcCtD
Clofarabine—Asthenia—Methotrexate—psoriasis	3.54e-05	0.000201	CcSEcCtD
Clofarabine—Nausea—Prednisone—psoriasis	3.51e-05	0.000199	CcSEcCtD
Clofarabine—ABCG2—Metabolism—CYP2S1—psoriasis	3.5e-05	0.00219	CbGpPWpGaD
Clofarabine—Pruritus—Methotrexate—psoriasis	3.49e-05	0.000198	CcSEcCtD
Clofarabine—RRM1—Metabolism—CAT—psoriasis	3.42e-05	0.00214	CbGpPWpGaD
Clofarabine—Diarrhoea—Methotrexate—psoriasis	3.38e-05	0.000191	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	3.28e-05	0.00205	CbGpPWpGaD
Clofarabine—Dizziness—Methotrexate—psoriasis	3.26e-05	0.000185	CcSEcCtD
Clofarabine—Vomiting—Methotrexate—psoriasis	3.14e-05	0.000178	CcSEcCtD
Clofarabine—Rash—Methotrexate—psoriasis	3.11e-05	0.000176	CcSEcCtD
Clofarabine—Dermatitis—Methotrexate—psoriasis	3.11e-05	0.000176	CcSEcCtD
Clofarabine—Headache—Methotrexate—psoriasis	3.09e-05	0.000175	CcSEcCtD
Clofarabine—Nausea—Methotrexate—psoriasis	2.93e-05	0.000166	CcSEcCtD
Clofarabine—RRM2—Metabolism—CAT—psoriasis	2.81e-05	0.00176	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—APOE—psoriasis	2.66e-05	0.00166	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CAT—psoriasis	2.63e-05	0.00164	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PPARG—psoriasis	2.31e-05	0.00145	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—APOE—psoriasis	2.19e-05	0.00137	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—TP53—psoriasis	2.08e-05	0.0013	CbGpPWpGaD
Clofarabine—DCK—Metabolism—APOE—psoriasis	2.04e-05	0.00128	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PPARG—psoriasis	1.91e-05	0.00119	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PPARG—psoriasis	1.78e-05	0.00111	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CARM1—psoriasis	1.71e-05	0.00107	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TP53—psoriasis	1.42e-05	0.000887	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CAT—psoriasis	1.05e-05	0.000658	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—APOE—psoriasis	8.18e-06	0.000511	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PPARG—psoriasis	7.12e-06	0.000445	CbGpPWpGaD
